title: Comments on Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group, van Zandwijk et al., Eur J Cancer 1997, 33, 1759-1766.
authors.forename: C
authors.initials: C
authors.lastname: Prior
authors.forename: J
authors.initials: J
authors.lastname: Thaler
authors.forename: H
authors.initials: H
authors.lastname: Huber
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000628:therapy*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D007371:Interferon-gamma